GNMSF | Genmab A/S Annual & Quarterly Balance Sheets

Annual Balance Sheets

(In DKK)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	35.28 Billion	30.27 Billion	24.62 Billion	21.14 Billion	15.14 Billion	8.46 Billion
Total Current Assets	33.13 Billion	28.37 Billion	22.73 Billion	18.79 Billion	13.96 Billion	7.43 Billion
Cash And Short Term Investments	28.13 Billion	22.32 Billion	19.33 Billion	16.07 Billion	10.97 Billion	6.1 Billion
Cash and Cash Equivalents	14.86 Billion	9.89 Billion	8.95 Billion	7.26 Billion	3.55 Billion	532.9 Million
Short Term Investments	13.26 Billion	12.43 Billion	10.38 Billion	8.81 Billion	7.41 Billion	5.57 Billion
Net Receivables	4.94 Billion	6.05 Billion	3.39 Billion	2.71 Billion	2.99 Billion	1.32 Billion
Inventory	57 Million	-182 Million	-31 Million	-249 Million	-	-
Other Current Assets	-	182 Million	31 Million	249 Million	-	-
Total Non-Current Assets	2.15 Billion	1.9 Billion	1.89 Billion	2.35 Billion	1.18 Billion	1.02 Billion
Net PPE	1.64 Billion	1.32 Billion	975 Million	736 Million	414 Million	161.54 Million
Good Will And Intangible Assets	101 Million	146 Million	254 Million	338 Million	470 Million	470.35 Million
Good Will	-	-	-	-	-	-
Intangible Assets	101 Million	146 Million	254 Million	338 Million	470 Million	470.35 Million
Long-Term Investments	196 Million	133 Million	371 Million	1.08 Billion	149 Million	9.62 Million
Tax Assets	212 Million	252 Million	264 Million	177 Million	139 Million	386.44 Million
Other Non Current Assets	-	48 Million	27 Million	20 Million	11 Million	-
Other Assets	-	-	-	-	-	-
Total Liabilities	3.67 Billion	2.83 Billion	2.43 Billion	2.02 Billion	1.09 Billion	446.63 Million
Total Current Liabilities	2.48 Billion	1.82 Billion	1.56 Billion	1.25 Billion	938 Million	443.34 Million
Account Payables	2.3 Billion	1.71 Billion	350 Million	1.18 Billion	839 Million	316.38 Million
Tax Payables	54 Million	-	-	-	73 Million	126.96 Million
Short Term Debt	90 Million	74 Million	62 Million	42 Million	26 Million	-
Deferred Revenue	33 Million	33 Million	26 Million	26 Million	-839 Million	-
Other Current Liabilities	54 Million	-	1.13 Billion	-	912 Million	126.96 Million
Total Non Current Liabilities	1.19 Billion	1.01 Billion	863 Million	769 Million	158 Million	3.29 Million
Long-Term Debt	680 Million	523 Million	363 Million	277 Million	155 Million	-
Deferred Revenue Non Current	480 Million	480 Million	487 Million	487 Million	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	35 Million	11 Million	13 Million	5 Million	3 Million	3.29 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	31.61 Billion	27.44 Billion	22.19 Billion	19.12 Billion	14.04 Billion	8.01 Billion
Stock Holders Equity	31.61 Billion	27.44 Billion	22.19 Billion	19.12 Billion	14.04 Billion	8.01 Billion
Common Stock	66 Million	66 Million	66 Million	66 Million	65 Million	61.49 Million
Retained Earnings	19.02 Billion	14.96 Billion	10.02 Billion	7.1 Billion	2.13 Billion	-197.45 Million
Accumulated other comprehensive income	60 Million	98 Million	81 Million	54 Million	98 Million	91.7 Million
Common Stock Equity	31.61 Billion	27.44 Billion	22.19 Billion	19.12 Billion	14.04 Billion	8.01 Billion
Capital Lease Obligation	680 Million	597 Million	425 Million	319 Million	181 Million	-
Total Investments	13.46 Billion	12.56 Billion	10.75 Billion	9.9 Billion	7.56 Billion	5.57 Billion
Total Debt	770 Million	597 Million	425 Million	319 Million	181 Million	-
Net Debt	-14.09 Billion	-9.29 Billion	-8.53 Billion	-6.94 Billion	-3.37 Billion	-532.9 Million

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	38.61 Billion	36.68 Billion	35.28 Billion	35.28 Billion	35.23 Billion	31.97 Billion
Total Current Assets	21.93 Billion	34.36 Billion	33.13 Billion	33.13 Billion	33.02 Billion	29.74 Billion
Cash And Short Term Investments	15.73 Billion	29.58 Billion	28.13 Billion	28.13 Billion	27.52 Billion	24.88 Billion
Cash and Cash Equivalents	4.33 Billion	14.67 Billion	14.86 Billion	14.86 Billion	14.27 Billion	10.87 Billion
Short Term Investments	11.4 Billion	14.91 Billion	13.26 Billion	13.26 Billion	13.25 Billion	14.01 Billion
Net Receivables	6.16 Billion	4.67 Billion	4.94 Billion	4.94 Billion	5.43 Billion	4.81 Billion
Inventory	36 Million	106 Million	57 Million	57 Million	70 Million	51 Million
Other Current Assets	-	-	-	-	-	124 Million
Total Non-Current Assets	16.68 Billion	2.31 Billion	2.15 Billion	2.15 Billion	2.21 Billion	2.22 Billion
Net PPE	1.88 Billion	1.86 Billion	1.64 Billion	1.64 Billion	1.65 Billion	1.63 Billion
Good Will And Intangible Assets	14.52 Billion	23 Million	101 Million	101 Million	115 Million	129 Million
Good Will	2.51 Billion	-	-	-	-	-
Intangible Assets	12.01 Billion	23 Million	101 Million	101 Million	115 Million	129 Million
Long-Term Investments	273 Million	216 Million	196 Million	196 Million	156 Million	183 Million
Tax Assets	-12.01 Billion	212 Million	212 Million	212 Million	252 Million	252 Million
Other Non Current Assets	12.01 Billion	-	-	-	37 Million	31 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	7.65 Billion	4.18 Billion	3.67 Billion	3.67 Billion	4.12 Billion	3.22 Billion
Total Current Liabilities	4.36 Billion	2.75 Billion	2.48 Billion	2.48 Billion	2.9 Billion	1.99 Billion
Account Payables	3.4 Billion	2.51 Billion	2.3 Billion	2.3 Billion	2.34 Billion	1.87 Billion
Tax Payables	837 Million	122 Million	54 Million	54 Million	445 Million	-
Short Term Debt	94 Million	92 Million	90 Million	90 Million	83 Million	82 Million
Deferred Revenue	33 Million	33 Million	33 Million	33 Million	33 Million	33 Million
Other Current Liabilities	837 Million	122 Million	54 Million	54 Million	445 Million	-
Total Non Current Liabilities	3.28 Billion	1.42 Billion	1.19 Billion	1.19 Billion	1.22 Billion	1.23 Billion
Long-Term Debt	925 Million	918 Million	680 Million	680 Million	710 Million	721 Million
Deferred Revenue Non Current	480 Million	480 Million	480 Million	480 Million	480 Million	480 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	28 Million	26 Million	35 Million	35 Million	34 Million	29 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	30.96 Billion	32.49 Billion	31.61 Billion	31.61 Billion	31.11 Billion	28.75 Billion
Stock Holders Equity	30.96 Billion	32.49 Billion	31.61 Billion	31.61 Billion	31.11 Billion	28.75 Billion
Common Stock	66 Million	66 Million	66 Million	66 Million	66 Million	66 Million
Retained Earnings	18.13 Billion	19.8 Billion	19.02 Billion	19.02 Billion	18.45 Billion	16.16 Billion
Accumulated other comprehensive income	234 Million	108 Million	60 Million	60 Million	142 Million	112 Million
Common Stock Equity	30.96 Billion	32.49 Billion	31.61 Billion	31.61 Billion	31.11 Billion	28.75 Billion
Capital Lease Obligation	925 Million	918 Million	680 Million	680 Million	793 Million	803 Million
Total Investments	11.67 Billion	15.13 Billion	13.46 Billion	13.46 Billion	13.4 Billion	14.19 Billion
Total Debt	1.01 Billion	1.01 Billion	770 Million	770 Million	793 Million	803 Million
Net Debt	-3.31 Billion	-13.66 Billion	-14.09 Billion	-14.09 Billion	-13.48 Billion	-10.07 Billion

Balance Sheet Charts

QNB Finansbank A.S.

QNBFB

Full Analysis

Annual Balance Sheets
ARYx Therapeutics, Inc.

ARYX

Full Analysis

Annual Balance Sheets
Water Oasis Group Limited

WOSSF

Full Analysis

Annual Balance Sheets
Cardinal Health, Inc.

0HTG

Full Analysis

Annual Balance Sheets
NTT DATA Corporation

9613

Full Analysis

Annual Balance Sheets
Swissquote Group Holding Ltd

0QLD

Full Analysis

Annual Balance Sheets

Global Stocks Search

Genmab A/S (GNMSF)

Annual Balance Sheets

Balance Sheet Charts

QNB Finansbank A.S.

ARYx Therapeutics, Inc.

Water Oasis Group Limited

Cardinal Health, Inc.

NTT DATA Corporation

Swissquote Group Holding Ltd